Prof.SUGIMOTO

• Professor
  • Mikio SUGIMOTO, M.D., Ph.D.
• Associate Professor
  • Rikiya TAOKA, M.D., Ph.D.
• Lecturer
  • Homare OKAZOE, M.D., Ph.D.
• Assistant Professor
  • Takuma KATO, M.D., Ph.D.
  • Yoichiro TOHI, M.D., Ph.D.
  • Hirohito NAITO, M.D., Ph.D.
  • Xia ZHANG, Ph.D.
• Clinical Assistant Professor
  • Yohei ABE, M.D.
  • Kana KOHASHIGUCHI, M.D.
• Clinical Fellow
  • Iori MATSUDA, M.D.
  • Naoya KANI, M.D.
  • Shunsuke NAKAMURA, M.D.
  • Sayo MATSUMOTO, M.D.

• Study on safety and feasibility of active surveillance for localized prostate cancer.
• Research for chronic prostatitis which is a cause of benign prostate hypertrophy and urinary symptoms.
• Development of a novel diagnostic tool for chronic prostatitis.
• Study on antitumor effect of rare sugar on urological cancers.

• Kato T, Tohi Y, Takamoto A, Shimizu R, Daizumoto K, Katayama S, Kobayashi K, Morinaka H, Nishimura K, Fukuhara H, Morizane S, Furukawa J, Araki M, Shiraishi K, Miyaji Y, Miura N, Inoue K, Sugimoto M; Chu-Shikoku Japan Urological Consortium. Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel. Int J Clin Oncol. 2026 May;31(5):834-842.
• Abe Y, Taoka R, Kaji A, Harada S, Fujiwara K, Kohashiguchi K, Naito H, Tohi Y, Kato T, Okazoe H, Ueda N, Sugimoto M. Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched Analysis. Int J Urol. 2026 Feb;33(2):e70365.
• Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M. Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial. Int J Urol. 2026 Jan;33(1):e70328. 

E-mail:

 >> Lab Homepage